SUZHOU ZELGEN BIOPHARMACEUTICALS COSUZHOU ZELGEN BIOPHARMACEUTICALS COSUZHOU ZELGEN BIOPHARMACEUTICALS CO

SUZHOU ZELGEN BIOPHARMACEUTICALS CO

No trades
See on Supercharts

688266 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Suzhou Zelgen Biopharmaceuticals Co., Ltd. engages in the innovation, research, development, manufacturing, and commercialization of new medications. Its products include tablets and capsules of small molecule drugs and protein drugs, which are mainly for the treatments of cancer and hematologic diseases. The company was founded by Ze Lin Sheng, Hui Ping Lu, and Su Liu on March 18, 2009 and is headquartered in Kunshan, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
688266 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company